Muscle Weakness clinical trials

Explore recruiting muscle weakness clinical trials.

Recruiting muscle weakness studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Muscle Weakness trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 2b randomized, double-blind, placebo-controlled crossover study evaluating the efficacy and safety of zagociguat in participants with MELAS (PRIZM)

Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of Botulinum TOXin type A in the treatment of Buerger’s disease

France

Phase II and Phase III (Integrated) EU CTIS Study details

The effect of nocturnal dexmedetomidine on postoperative sleep quality and fatigue after major surgery in elderly patients: DEXSLEEP study

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

The effect of corticosteroids on early recovery after major surgery in eldery patients: CORTERAS study

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Botulinum toxin in open abdomen closure. A multicentric randomized controlled single-blind clinical trial to evaluate the efficacy of early administration of botulinum toxin for primary midline closure in patients with an open abdomen.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

BIRD - Baricitinib in patients with relapsing or naive Dermatomyositis

France

Phase II and Phase III (Integrated) EU CTIS Study details

Muscle Weakness trials by city

Muscle Weakness in Toronto Muscle Weakness in Vancouver Muscle Weakness in Montreal Muscle Weakness in Calgary Muscle Weakness in Edmonton Muscle Weakness in Ottawa Muscle Weakness in Winnipeg Muscle Weakness in Quebec City Muscle Weakness in Hamilton Muscle Weakness in Kitchener Muscle Weakness in London Muscle Weakness in Halifax Muscle Weakness in New York Muscle Weakness in Los Angeles Muscle Weakness in Chicago Muscle Weakness in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease